// OVERVIEW
Private equity firm backing Belron ahead of its Amsterdam IPO.
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
m_and_a·Axios Pro Rata·OCTOBER 6, 2026
“CD&R and McKesson (NYSE: MCK) agreed to buy medical infusion company Option Care (Nasdaq: OPCH) for $5.8b, or $32.05 per share (37% premium on yesterday's closing price).”
02
mention·PitchBook News·APRIL 20, 2026
“Belron | Car windshield repair (Safelite parent) | CD&R-backed; preparing €30B IPO in Amsterdam”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.